GGHC
Gilder Gagnon Howe & Co’s Adaptive Biotechnologies ADPT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-1,245,111
| Closed | -$4M | – | 252 |
|
2024
Q1 | $4M | Buy |
1,245,111
+11,597
| +0.9% | +$37.2K | 0.05% | 160 |
|
2023
Q4 | $6.04M | Buy |
1,233,514
+9,396
| +0.8% | +$46K | 0.08% | 140 |
|
2023
Q3 | $6.67M | Buy |
1,224,118
+8,593
| +0.7% | +$46.8K | 0.1% | 127 |
|
2023
Q2 | $8.16M | Buy |
1,215,525
+46,005
| +4% | +$309K | 0.11% | 127 |
|
2023
Q1 | $10.3M | Buy |
+1,169,520
| New | +$10.3M | 0.17% | 105 |
|
2022
Q1 | – | Sell |
-942,666
| Closed | -$26.5M | – | 291 |
|
2021
Q4 | $26.5M | Sell |
942,666
-1,027,060
| -52% | -$28.8M | 0.15% | 124 |
|
2021
Q3 | $67M | Sell |
1,969,726
-80,237
| -4% | -$2.73M | 0.35% | 71 |
|
2021
Q2 | $83.8M | Sell |
2,049,963
-334,242
| -14% | -$13.7M | 0.41% | 68 |
|
2021
Q1 | $96M | Buy |
2,384,205
+9,407
| +0.4% | +$379K | 0.52% | 57 |
|
2020
Q4 | $140M | Sell |
2,374,798
-22,481
| -0.9% | -$1.33M | 0.7% | 40 |
|
2020
Q3 | $117M | Sell |
2,397,279
-57,990
| -2% | -$2.82M | 0.72% | 43 |
|
2020
Q2 | $119M | Buy |
2,455,269
+176,019
| +8% | +$8.52M | 0.93% | 30 |
|
2020
Q1 | $63.3M | Buy |
2,279,250
+1,494,052
| +190% | +$41.5M | 0.76% | 44 |
|
2019
Q4 | $23.5M | Sell |
785,198
-7,423
| -0.9% | -$222K | 0.24% | 93 |
|
2019
Q3 | $24.5M | Buy |
792,621
+200,872
| +34% | +$6.21M | 0.28% | 92 |
|
2019
Q2 | $28.6M | Buy |
+591,749
| New | +$28.6M | 0.29% | 88 |
|